The Investigational New Drug Workshop

March 5, 2021 - 9:00am to 11:00am
Rachel Johnson, PhD, RAC and Katherine Deland, PhD

Define an investigational drug, including off-label use of FDA approved drugs Provide guidance on determining when the IND regulations apply to research studies
Discuss the preparation and submission of IND applications to FDA
Review maintenance and safety reporting requirements
Review case scenarios